title: Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.
authors.forename: C
authors.initials: C
authors.lastname: Bouchardy
authors.forename: H M
authors.initials: HM
authors.lastname: Verkooijen
authors.forename: G
authors.initials: G
authors.lastname: Fioretta
authors.forename: A P
authors.initials: AP
authors.lastname: Sappino
authors.forename: G
authors.initials: G
authors.lastname: Vlastos
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015994:Incidence; D018200:Mixed Tumor, Mullerian / Q000139:chemically induced* / Q000453:epidemiology; D012042:Registries; D012307:Risk Factors; D013557:Switzerland / Q000453:epidemiology; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen